Jens Passauer
Nephrology
Department of Medicine
University Hospital Dresden
Germany
Name/email consistency: high
- Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study. Passauer, J., Petrov, H., Schleser, A., Leicht, J., Pucalka, K. Nephrol. Dial. Transplant. (2010)
- A single lipid apheresis does not modulate pulse wave reflection in hypercholesterolemic patients. Passauer, J., Herbrig, K., Fischer, S., Bornstein, S., Julius, U. Atheroscler. Suppl (2009)
- Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. Passauer, J., Pistrosch, F., Büssemaker, E., Lässig, G., Herbrig, K., Gross, P. J. Am. Soc. Nephrol. (2005)
- Nitric oxide in chronic renal failure. Passauer, J., Pistrosch, F., Büssemaker, E. Kidney Int. (2005)
- Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9. Passauer, J., Pistrosch, F., Lässig, G., Herbrig, K., Büssemaker, E., Gross, P., Fleming, I. Kidney Int. (2005)
- Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients. Passauer, J., Lässig, G., Büssemaker, E., Pistrosch, F., Gross, P. Kidney Int. (2004)
- Kidney transplantation improves endothelium-dependent vasodilation in patients with endstage renal disease. Passauer, J., Büssemaker, E., Lassig, G., Gross, P. Transplantation (2003)
- Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole. Passauer, J., Büssemaker, E., Lässig, G., Pistrosch, F., Fauler, J., Gross, P., Fleming, I. Clin. Sci. (2003)
- Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilation in normotensive patients on chronic hemodialysis. Passauer, J., Büssemaker, E., Range, U., Plug, M., Gross, P. J. Am. Soc. Nephrol. (2000)